Product
Etravirine
3 clinical trials
3 indications
Indication
HIV InfectionsIndication
HIV-1Indication
Friedreich AtaxiaClinical trial
Open-Label, Single-Sequence Study to Evaluate the Effects of Darunavir/Ritonavir and/or Etravirine on the Pharmacokinetics of GSK3640254 and the Effects of GSK3640254 on the Pharmacokinetics of Darunavir/Ritonavir and/or Etravirine in Heathy AdultsStatus: Completed, Estimated PCD: 2021-10-02
Clinical trial
Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected SubjectsStatus: Active (not recruiting), Estimated PCD: 2020-11-01
Clinical trial
A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia PatientsStatus: Completed, Estimated PCD: 2023-01-17